Serum Total Oxidant/anti-oxidant Status, Ischemia-modified Albumin and Oxidized-low Density Lipoprotein Levels in Patients with Vitamin D Deficiency
Overview
Authors
Affiliations
Objective: Oxidative damage may be responsible for the pathogenesis and complications of many diseases. Vitamin D deficiency has been suggested as a potential mediator of various extra-skeletal pathologies. However, there are limited data on anti-oxidant properties of vitamin D.
Materials And Methods: Forty-one subjects with vitamin D deficiency and 30 healthy controls were enrolled into the study. The levels of total anti-oxidant status (TAS), total oxidant status (TOS), ischemia-modified albumin (IMA), oxidized-low density lipoprotein (ox-LDL), high-sensitivity C-reactive protein (hs-CRP) and fibrinogen were measured in both groups. The measurements were repeated in 17 patients after the replacement of vitamin D.
Results: Serum IMA and TOS levels were significantly higher (p < 0.001 and p = 0.035, respectively), while TAS levels were significantly lower in patients, compared to controls (p < 0.001). Additionally, fibrinogen was significantly higher in patients than controls (p = 0.003), while ox-LDL and hs-CRP levels were similar between two groups. After the replacement of vitamin D, TAS level significantly increased (p = 0.037), and TOS and fibrinogen levels significantly decreased (p = 0.043 and p = 0.010, respectively). Vitamin D levels were negatively correlated with IMA and fibrinogen levels (r = -0.500, p < 0.001 and r = -0.391, p = 0.002, respectively), although positively correlated with TAS levels (r = 0.430, p < 0.001). No correlation was found between vitamin D levels, and the TOS, ox-LDL and hs-CRP levels.
Conclusions: In this study, while serum IMA, TOS and fibrinogen levels were increased, TAS levels were seen to be decreased in patients with vitamin D deficiency. These results suggest that oxidative/anti-oxidative balance shifts in favours of oxidative status in vitamin D deficiency.
Onyango A, Shaviya N, Budambula V, Orinda G, Anzala O, Aabid A BMC Infect Dis. 2024; 24(1):703.
PMID: 39020290 PMC: 11256408. DOI: 10.1186/s12879-024-09610-8.
Zorlu M, Sekerci A, Tunc M, Guler E, Gulen B, Karatoprak C Turk J Med Sci. 2022; 52(4):1197-1206.
PMID: 36326375 PMC: 10388050. DOI: 10.55730/1300-0144.5424.
Molani Gol R, Rafraf M, Jafarabadi M Health Promot Perspect. 2018; 8(4):315-322.
PMID: 30479987 PMC: 6249489. DOI: 10.15171/hpp.2018.45.
The Decline in Vitamin Research Funding: A Missed Opportunity?.
Chambers J, Anderson J, Salem M, Bugel S, Fenech M, Mason J Curr Dev Nutr. 2018; 1(8):e000430.
PMID: 29955714 PMC: 5998363. DOI: 10.3945/cdn.117.000430.
Vellekkatt F, Menon V J Postgrad Med. 2018; 65(2):74-80.
PMID: 29943744 PMC: 6515787. DOI: 10.4103/jpgm.JPGM_571_17.